Aevi Genomic Medicine (GNMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2011 | |
| Operating Expenses | 17,818 | 12,628 | 9,976 |
| Operating Income | -17,818 | -12,628 | -9,976 |
| Other Income | 706 | -2,424 | 1,883 |
| Pre-tax Income | -17,112 | -15,052 | -8,093 |
| Income Tax | 17 | 19 | 3 |
| Net Income Continuous | -17,129 | -15,071 | -8,096 |
| Net Income | $-17,129 | $-15,071 | $-8,096 |
| EPS Basic Total Ops | -0.97 | -1.37 | -0.96 |
| EPS Basic Continuous Ops | -0.97 | -1.37 | -0.96 |
| EPS Diluted Total Ops | -1.06 | -1.37 | -0.96 |
| EPS Diluted Continuous Ops | -0.97 | -1.37 | -0.96 |
| EPS Diluted Before Non-Recurring Items | -1.06 | N/A | N/A |
| EBITDA(a) | $-17,641 | $-12,483 | $-9,878 |